Skip to content
Dosage GuideResearch Reference

Cerebrolysin Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Cerebrolysin. All information is for educational purposes only.

Quick Answer

Cerebrolysin dosage varies depending on the indication, but typically ranges from 5 mL to 50 mL administered intravenously or intramuscularly. For acute stroke, higher doses (30-50 mL) are often used within the first 72 hours. For Alzheimer's disease and other chronic neurological conditions, lower doses (5-30 mL) are more common.

→ Cerebrolysin Benefits→ Cerebrolysin Side Effects→ Full Cerebrolysin Profile
Table of Contents

Standard Dosage Range

Research dosing range: 5–50 mL per dose (IV/IM)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Acute Ischemic Stroke

30–50 mL1× daily
Duration

10–21 days

Administer intravenously within 72 hours of stroke onset. Some protocols use loading doses initially. Monitor blood pressure closely.

Alzheimer's Disease

5–30 mL3–5× per week
Duration

4–12 weeks

Administer intravenously or intramuscularly. Lower doses may be sufficient for maintenance therapy. Clinical trials often use a 30 mL dose, but start lower to assess tolerability

Traumatic Brain Injury

10–30 mL1× daily
Duration

4–8 weeks

Administer intravenously or intramuscularly. Dosage may be adjusted based on injury severity and patient response. Initiate treatment as early as possible after the injury.

Vascular Dementia

5–20 mL3× per week
Duration

4–12 weeks

Administer intravenously or intramuscularly. Monitor cognitive function and adjust dosage accordingly. May improve cerebral blood flow and cognitive performance.

Cognitive Enhancement (Off-label)

5–10 mL1–3× per week
Duration

4–8 weeks

Administer intravenously or intramuscularly. This is an off-label use and should be approached with caution. Limited evidence supports its use for general cognitive enhancement in healthy individuals. Closely monitor for adverse effects.

Timing & Frequency

For acute stroke, administer as soon as possible after symptom onset. For chronic conditions, administration timing is less critical but consistent timing is preferred (e.g., same time each day or week).

Cycle Guidance

Cycles typically range from 4 to 12 weeks, followed by a break of equal duration. Long-term continuous use is not well-studied, so cycling is recommended to minimize potential long-term side effects.

Reconstitution Reference

Quick reference for reconstituting Cerebrolysin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeSupplied as a pre-mixed solution in ampules
BAC Water VolumeNot applicable (pre-mixed)
Concentration & DrawVaries based on the product (typically 21.52 mg/mL of peptide fraction)
StorageStore ampules at room temperature (15-25°C) and protect from light. Do not freeze.
StabilityShelf life is typically 3 years when stored properly. Once opened, use immediately; do not store unused portions.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the typical Cerebrolysin dosage for stroke recovery?
For acute ischemic stroke, a typical dosage is 30-50 mL administered intravenously once daily for 10-21 days, initiated within 72 hours of stroke onset. Higher doses may be used initially as a loading dose.
How is Cerebrolysin administered?
Cerebrolysin can be administered intravenously or intramuscularly. Intravenous administration is preferred for higher doses and acute conditions. Ensure proper injection technique and use sterile equipment to minimize the risk of infection.
Are there any contraindications for Cerebrolysin use?
Cerebrolysin is contraindicated in patients with severe renal impairment, epilepsy, and hypersensitivity to the drug or porcine proteins. Use with caution in patients with bleeding disorders or those taking anticoagulants.
What are the common side effects of Cerebrolysin?
Common side effects include injection site reactions (pain, redness, swelling), headache, dizziness, agitation, and insomnia. Less common side effects include seizures, fever, and allergic reactions. Monitor patients for adverse effects and adjust dosage accordingly.
Can Cerebrolysin be used in combination with other treatments?
Cerebrolysin can be used in conjunction with other treatments for stroke, Alzheimer's disease, and traumatic brain injury. However, it is important to consider potential drug interactions and adjust dosages accordingly. Consult with a healthcare professional before combining Cerebrolysin with other medications.

Last updated: 2026-02-19